Table 5 The relation between LVD and other parameters in 73 patients with T1 gastric cancer.
| Factor | N | Mean (SD) LVD/field | p Value |
|---|---|---|---|
| Sex | 0.2967 | ||
| Male | 52 | 10.50 (7.16) | |
| Female | 21 | 12.57 (8.06) | |
| Depth of invasion | 0.0008 | ||
| Mucosa | 32 | 8.06 (6.02) | |
| Submucosa | 41 | 13.6 (7.64) | |
| Lymph node metastasis | 0.0094 | ||
| Negative | 64 | 10.25 (7.09) | |
| Positive | 9 | 17.11 (7.54) | |
| Venous invasion | 0.3299 | ||
| Negative | 72 | 11.18 (7.46) | |
| Positive | 1 | 5 | |
| LVI‐HE | 0.0223 | ||
| Negative | 71 | 10.62 (6.97) | |
| Positive | 2 | 28 (2.83) | |
| LVI‐IHC | <0.001 | ||
| Negative | 59 | 9.21 (6.17) | |
| Positive | 14 | 18.40 (7.64) |
LVD, podoplanin positive lymph vessel density; LVI‐HE, lymph vessel invasion detected by haematoxylin and eosin staining; LVI‐IHC, lymph vessel invasion detected by podoplanin immunohistochemistry.